FMR LLC boosted its position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 51.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,528,512 shares of the company's stock after purchasing an additional 856,838 shares during the quarter. FMR LLC owned about 7.36% of The Pennant Group worth $90,268,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in PNTG. Vanguard Group Inc. boosted its stake in The Pennant Group by 4.3% in the 1st quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company's stock valued at $36,505,000 after purchasing an additional 77,052 shares during the period. Federated Hermes Inc. raised its holdings in shares of The Pennant Group by 600.0% during the 2nd quarter. Federated Hermes Inc. now owns 54,045 shares of the company's stock worth $1,253,000 after buying an additional 46,324 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of The Pennant Group by 17.1% during the 2nd quarter. Renaissance Technologies LLC now owns 267,300 shares of the company's stock worth $6,199,000 after buying an additional 39,000 shares in the last quarter. Premier Fund Managers Ltd acquired a new position in shares of The Pennant Group during the 3rd quarter worth $976,000. Finally, Navellier & Associates Inc. acquired a new position in shares of The Pennant Group during the 3rd quarter worth $874,000. 85.88% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on PNTG shares. Truist Financial boosted their price target on The Pennant Group from $34.00 to $38.00 and gave the stock a "hold" rating in a report on Monday, October 7th. Stephens reiterated an "overweight" rating and issued a $40.00 target price on shares of The Pennant Group in a research report on Wednesday, October 9th. Oppenheimer increased their target price on The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a research report on Friday, November 8th. Finally, Royal Bank of Canada increased their target price on The Pennant Group from $26.00 to $38.00 and gave the company an "outperform" rating in a research report on Wednesday, October 23rd.
Check Out Our Latest Analysis on The Pennant Group
The Pennant Group Trading Up 0.3 %
Shares of PNTG stock traded up $0.09 on Friday, hitting $29.92. The company had a trading volume of 186,621 shares, compared to its average volume of 200,475. The firm has a market cap of $1.03 billion, a P/E ratio of 44.00, a P/E/G ratio of 3.16 and a beta of 1.95. The stock's 50-day moving average is $32.77 and its two-hundred day moving average is $29.75. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The Pennant Group, Inc. has a twelve month low of $13.24 and a twelve month high of $37.13.
About The Pennant Group
(
Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.